Period of time： 2014年2期
Publisher： Informa Healthcare
Founded in： 1996
Total resources： 42
ISSN： 1472-8214
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 6,issue 2
Menu
Prospects and problems of gene therapy: an update
By Górecki Dariusz C in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.
Access to resources
Recommend
Emerging therapies for human papillomavirus infection
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Fusion/entry inhibitors as therapies for HIV
By Redshaw Sally,Westby Mike in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors
By Andreola Marie-Line,Nguyen Chi Hung,Ventura Michel,Tarrago-Litvak Laura,Legraverend Michel in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Medications for the treatment of narcolepsy
By Black Jed,Guilleminault Christian in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Emerging drugs for neuropathic pain
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Biological activity of plant extracts: novel analgesic drugs
By Calixto João B,Scheidt Cristiano,Otuki Michel,Santos Adair RS in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Pharmacological treatment for prevention of restenosis
By Linde Jacek,Strauss Bradley H in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.Drugs targeted against protein kinases
By Kumar C Chandra,Madison Vincent in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.A therapeutic area review of oncology products and players
By Fleming Scott,Lucas François,Schofield Malcolm in (2001)
Expert Opinion on Emerging Drugs,volume 6,issue 2 , Vol. 6, Iss. 2, 2001-10 , pp.
Previous
Next